Nonsurgical rejuvenation of the face with botulinum toxin is one of the most commonly performed procedures in the United States. This article reviews the current evidence in treating different regions of the face: upper face, lower face, masseter, and platysma. Dosing and complications associated with different facial regions are reviewed.Learning Objectives
After viewing this course, the participant should be able to:
- Compare and contrast the various types of botulinum toxin on the market.
- Appropriately select patients for treatment with cosmetic botulinum toxin.
- Understand the common injection patterns for treating various regions of the face with cosmetic botulinum toxin.
- List the complications associated with treating various regions of the face with cosmetic botulinum toxin.
Lindsay E. Janes, M.D.; Lauren M. Connor, M.D.; Amir Moradi, M.D.; Mohammed Alghoul, M.D.
Plastic and Reconstruction Surgery®Editors:
Editor-in-Chief: Rod J. Rohrich, MD
Co-Editor: James M. Stuzin, MD
Section Editors: Donald H. Lalonde, MD; John YS Kim, MD
AMA PRA Category 1 CreditTM: 1.0
Patient Safety Credit: 0.5
Release Date: 03/25/2021
Expiration Date: 04/01/2024
Estimated time to complete this course: 1 hour
*Course access ends on course expiration date
Directly provided by the American Society of Plastic Surgeons® (ASPS®)
The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.
Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. Dr. Alghoul is on the advisory board for Allergan. Dr. Moradi has relationships with Allergan(consultant, advisory board, faculty, clinical research investigator), Merz Aesthetics (consultant, advisory board, member of steering committee, European expert summit, clinical research investigator), Galderma(consultant, advisory board, clinical research investigator),Skin Medica (consultant, advisory board, clinical research investigator), BTL (consultant, speaker, clinical research investigator), Lutronic (consultant, speaker, clinical research investigator), Alastin (consultant, clinical research investigator, stockholder),and Evolus (honorarium recipient).All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.
Return Policy for Downloaded and Viewable Products
Products which are downloaded or viewable after purchase may not be returned. By placing an order you are agreeing to the product return terms and conditions set forth by this site. ASPS Shop Return Policy
Product Code: 30955